Literature DB >> 12414411

Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery.

Christopher N Ta1, Peter R Egbert, Kuldev Singh, Erin M Shriver, Mark S Blumenkranz, Herminia Miño De Kaspar.   

Abstract

PURPOSE: To determine the efficacy of reducing conjunctival bacterial flora with topical ofloxacin when given for 3 days compared with 1 hour before surgery.
DESIGN: Prospective, randomized, controlled trial. PARTICIPANTS: Ninety-two eyes from 89 patients were randomized to a control group (48 eyes) or study group (44 eyes).
METHODS: All patients from both groups received topical ofloxacin 0.3% 1 hour before surgery and a 5% povidone iodine scrub of the periorbital area before surgery. The patients in the study group received additional ofloxacin four times daily for 3 days before surgery. MAIN OUTCOME MEASURES: Conjunctival cultures were obtained at five separate time points and were inoculated in solid and liquid culture media. The presence of bacteria was determined, quantified, and identified.
RESULTS: Forty-two percent of eyes in the control group had positive conjunctival culture immediately before surgery, compared with 19% of eyes in the study group (P < 0.05). Immediately after surgery, 34% and 14% of eyes had positive cultures in the control and study groups, respectively (P < 0.05). Quantitatively, fewer bacteria were isolated from eyes in the study group compared with those in the control group for culture samples that were obtained both before povidone iodine scrub and at the conclusion of surgery (P </= 0.05).
CONCLUSIONS: The application of topical ofloxacin for 3 days before surgery appears to be more effective in eliminating bacteria from the conjunctiva than an application of ofloxacin 1 hour before surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414411     DOI: 10.1016/s0161-6420(02)01236-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials.

Authors:  Abdhish R Bhavsar; Michael S Ip; Adam R Glassman
Journal:  Am J Ophthalmol       Date:  2007-09       Impact factor: 5.258

2.  Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review.

Authors:  Francesca Menchini; Giacomo Toneatto; Alba Miele; Simone Donati; Paolo Lanzetta; Gianni Virgili
Journal:  Eye (Lond)       Date:  2018-06-11       Impact factor: 3.775

3.  Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye.

Authors:  Tuomo Puustjärvi; Markku Teräsvirta; Pila Nurmenniemi; Jukka Lokkila; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

4.  Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.

Authors:  Federico Pea; Ettore Ferrari; Federica Pavan; Derri Roman-Pognuz; Francesco Bandello; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].

Authors:  M J Koss; M Eder; M S Blumenkranz; V Klauss; C N Ta; H M de Kaspar
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

6.  Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

Authors:  Abdhish R Bhavsar; Joseph M Googe; Cynthia R Stockdale; Neil M Bressler; Alexander J Brucker; Michael J Elman; Adam R Glassman
Journal:  Arch Ophthalmol       Date:  2009-12

7.  Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study.

Authors:  Yoshitsugu Inoue; Masahiko Usui; Yuichi Ohashi; Hiroshi Shiota; Tsutomu Yamazaki
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

8.  Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora.

Authors:  Jeff H Pettey; Mark D Mifflin; Randall J Olson
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-19       Impact factor: 2.671

9.  Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery.

Authors:  Frank A Bucci; Ruth E Evans; Loretta M Amico; Timothy W Morris; Angel T Fluet; Christine M Sanfilippo; Heleen H DeCory; Timothy L Comstock
Journal:  Clin Ophthalmol       Date:  2015-05-13

10.  A European perspective on topical ophthalmic antibiotics: current and evolving options.

Authors:  D Bremond-Gignac; F Chiambaretta; S Milazzo
Journal:  Ophthalmol Eye Dis       Date:  2011-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.